Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors
Condition(s):Medical OncologyLast Updated:November 7, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Medical OncologyLast Updated:November 7, 2019Completed
Condition(s):Cervical CancerLast Updated:February 27, 2019Unknown status
Condition(s):Non-Small-Cell Lung CancerLast Updated:October 12, 2022Recruiting
Condition(s):Malignant Pleural MesotheliomaLast Updated:November 7, 2022Active, not recruiting
Condition(s):Metastatic Non-squamous Non Small Cell Lung CancerLast Updated:May 24, 2017Completed
Condition(s):Head and Neck NeoplasmsLast Updated:June 24, 2009Completed
Condition(s):Histological or Cytological Confirmed Stage Ⅲ and Ⅳa ThymomaLast Updated:April 18, 2023Not yet recruiting
Condition(s):Epithelial Carcinoma, Ovarian; Neoadjuvant ChemotherapyLast Updated:August 10, 2021Unknown status
Condition(s):NSCLCLast Updated:February 4, 2019Withdrawn
Condition(s):Lung NeoplasmsLast Updated:February 28, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.